CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that it will report financial results for the third quarter of 2007 on Thursday, November 1, 2007, after the U.S. financial markets close. Management will provide an update on the company, discuss second quarter results, and discuss expectations for the future via conference call on Thursday, November 1, 2007, at 4:30 p.m. ET. To access the call, please dial 866-543-6407 (domestic) or 617-213-8898 (international) five minutes prior to the start time and provide the passcode 83805594. A replay of the call will be available from 6:30 p.m. ET on November 1, 2007 until November 8, 2007. To access the replay, please dial 888-286-8010 (domestic) or 617-801-6888 (international), and provide the passcode 60466589.
